ACO ame and Location Care4Texans, LLC 6901 Medical Parkway Waco, Texas 76712 ACO Primary Contact Primary Contact ame Katrina George Primary Contact Phone umber 254-751-4754 Primary Contact Email Address Katrina.George@ascension.org Organizational Information ACO participants: ACO Participants William A. Peper, M.D., P.A. Ballew & Associates Podiatry, P.A. (Waco Foot & Ankle P.A) McLennan County Hospitalist Services Todd A Moffatt MD, PA (Todd A Moffatt MD Surgery) Kenneth Ballew Waco Bone & Joint Clinic PA (Elite Sports Medicine) Central Texas ephrology Associates, P.A. Russell E Swann MD PA (Brazos Eye Surgery of Texas) Waco Orthopedic Clinic Surgical Clinic, PA (Waco Surgical Group) Central Texas Urologic Associates, P.A. Heart of Texas Community Health Center, Inc (Family Health Center) Central Texas Pathology Laboratory, P.A. Mid Tex Anesthesia Associates Pa ACO Participant in Joint Venture (Enter Y or ) ACO governing body:
Member Last ame First ame Title/Position Member's Voting Power Membership Type Becker Brian MD / Treasurer 1 ACO Participant Dreyer Lauren 1 Community Stakeholder Elwell Steven MD 1 ACO Participant Falcone Adam MD 1 Other /A Griggs Jackson MD 1 ACO Participant Hoffman David MD/Secretary 1 ACO Participant Horner Keith MD/Vice Chair 1 ACO Participant McHenry Clint MD 1 ACO Participant Province Steve 1 ACO Participant Shen Mark MD 1 ACO Participant Stevens Terry 1 Medicare Beneficiary Stewart Donald MD/Chair 1 ACO Participant Warren Joshua MD 1 ACO Participant ACO Participant TI Legal Business ame/dba, if Applicable /A McLennan County Hospitalist Services Heart of Texas Community Health Center, Inc /A Central Texas Urologic Associates, P.A. Key ACO clinical and administrative leadership: Katrina George ACO Executive W. Richard Haskett Medical Director Diana Horn Compliance Officer Katrina George Quality Assurance/Improvement Officer Associated committees and committee leadership: Committee ame Committee Leader ame and Position Executive Committee Dr. Donald Stewart, Chair Contracting & Finance Committee Dr. Jeffrey Manning, Chair Clinical Quality Committee Dr. David Hoffman, Co-Chair
ominating Committee Committee ame Committee Leader ame and Position Dr. Rodney Richie, Co-Chair Dr. Donald Stewart, Chair Types of ACO participants, or combinations of participants, that formed the ACO: Partnerships or joint venture arrangements between hospitals and ACO professionals Federally Qualified Health Center (FQHC) Shared Savings and Losses Amount of Shared Savings/Losses First Agreement Period o Performance Year 2016, $0 Shared Savings Distribution First Agreement Period o Performance Year 2016 Quality Performance Results 2016 Quality Performance Results:! Proportion invested in infrastructure: /A! Proportion invested in redesigned care processes/resources: /A! Proportion of distribution to ACO participants: /A ACO# Measure ame Rate ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 85.31 79.9 ACO Mean ACO-2 CAHPS: How Well Your Providers Communicate 94.68 92.63 ACO-3 CAHPS: Patients' Rating of Provider 94.07 91.93 ACO-4 CAHPS: Access to Specialists 84.24 83.52 ACO-5 CAHPS: Health Promotion and Education 59.71 60 ACO-6 CAHPS: Shared Decision Making 77.83 75.28 ACO-7 CAHPS: Health Status/Functional Status 69.82 71.82 ACO-34 CAHPS: Stewardship of Patient Resources 38.15 27.52 ACO-8 Risk-Standardized, All Condition Readmission 14.17 14.7 ACO-35 Skilled ursing Facility 30-Day All-Cause Readmission Measure (SFRM) 17.65 18.17 ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 54.65 53.2 ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 71.41 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 60.92 59.81 ACO-9 Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 12.07 9.27 ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 ) 13.79 14.53 ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 86.15 82.72 ACO-39 Documentation of Current Medications in the Medical Record 83.52 87.54 ACO-13 Falls: Screening for Future Fall Risk 37.89 64.04 ACO-14 Preventive Care and Screening: Influenza Immunization 63.58 68.32 ACO-15 Pneumonia Vaccination Status for Older Adults 74.3 69.21 ACO-16 ACO-17 ACO-18 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention Preventive Care and Screening: Screening for Clinical Depression and Followup Plan 45.8 74.45 82.73 90.98 21.42 53.63 ACO-19 Colorectal Cancer Screening 57.9 61.52 ACO-20 Breast Cancer Screening 75.04 67.61 ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented 78.01 76.84 ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 74.87 77.72 ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 33.19 18.24 ACO-41 Diabetes: Eye Exam 35.28 44.94 ACO-28 Hypertension (HT): Controlling High Blood Pressure 58.7 70.52 ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 60.5 85.05 ACO-31 ACO-33 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 79.37 88.67 58.82 79.67 Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples. For 2016 Quality Performance Results please visit: https://data.cms.gov/special-programs- Initiatives-Medicare-Shared-Savin/2016-Shared-Savings-Program-SSP-Accountable-Care- O/3jk5-q6dr/data ote: In the Quality Performance Results file(s) above, search for Care4Texans, LLC to view the quality performance results. This ACO can also be found by using the ACO ID A19727 in the public use files on data.cms.gov.
Payment Rule Waivers o, our ACO does not use the SF 3-Day Rule Waiver.